Novavax Inc. said vaccine efficacy appeared to be preserved in those receiving an approved influenza vaccine along with the company’s Covid-19 vaccine candidate compared to those receiving its Covid-19 vaccine alone.
French drugmaker Sanofi and Britain’s GlaxoSmithKline started a clinical trial of their protein-based Covid-19 vaccine candidate, with the companies aiming to reach the final testing stage by December.
